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Background: Tuberculosis (TB) affects one third of the global population, and TB of the central nervous system
(CNS-TB) is the most severe form of tuberculosis which often associates with high mortality. The pro-inflammatory
cytokine tumour necrosis factor (TNF) plays a critical role in the initial and long-term host immune protection
against Mycobacterium tuberculosis (M. tuberculosis) which involves the activation of innate immune cells and
structure maintenance of granulomas. However, the contribution of TNF, in particular neuron-derived TNF, in the
control of cerebral M. tuberculosis infection and its protective immune responses in the CNS were not clear.
Methods: We generated neuron-specific TNF-deficient (NsTNF−/−) mice and compared outcomes of disease against
TNFf/f control and global TNF−/− mice. Mycobacterial burden in brains, lungs and spleens were compared, and
cerebral pathology and cellular contributions analysed by microscopy and flow cytometry after M. tuberculosis
infection. Activation of innate immune cells was measured by flow cytometry and cell function assessed by cytokine
and chemokine quantification using enzyme-linked immunosorbent assay (ELISA).
Results: Intracerebral M. tuberculosis infection of TNF−/− mice rendered animals highly susceptible, accompanied
by uncontrolled bacilli replication and eventual mortality. In contrast, NsTNF−/− mice were resistant to infection
and presented with a phenotype similar to that in TNFf/f control mice. Impaired immunity in TNF−/− mice was
associated with altered cytokine and chemokine synthesis in the brain and characterised by a reduced number of
activated innate immune cells. Brain pathology reflected enhanced inflammation dominated by neutrophil influx.
Conclusion: Our data show that neuron-derived TNF has a limited role in immune responses, but overall TNF
production is necessary for protective immunity against CNS-TB.
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Tuberculosis of the central nervous system (CNS-TB) is
associated with significant mortality and high distressing
levels of neurological morbidity, the majority of survivors
suffering permanent neurologic complications [1–3]. It
disproportionately affects children, especially in the devel-
oping world and immunocompromised individuals despite
the availability of anti-tuberculosis treatment [3–5]. The* Correspondence: muazzam.jacobs@uct.ac.za
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difficult. In Sub-Saharan African and some Asian coun-
tries, tuberculosis is now one of the most common forms
of bacterial meningitis due to the effects of HIV [6–8].
CNS-TB results from a rupture of subpial or subepen-
dymal foci which has been deposited earlier following
lympho-haematogenous dissemination of Mycobacter-
ium tuberculosis from the primary pulmonary infection,
or rupture of an adjacent parenchymal focus [1, 9]. It is
widely accepted that bacilli reach the CNS by a haema-
togenous route secondary to disease elsewhere in the
body. Since the brain parenchyma and the meninges are
physiologically and anatomically protected from thearticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
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(BBB), the mechanisms by which the bacilli initially
invade this barrier are not clear. It is believed that
M. tuberculosis can cross the BBB as a free organism or
via infected peripheral myeloid cells [10]. However, the
latter hypothesis seems controversial, as myeloid cellular
traffic is severely restricted into the CNS prior to inva-
sion by M. tuberculosis [11], however lymphoid cells in
physiological state can bypass the BBB by entering the
subarachnoid space via the meningeal veins or the chor-
oid plexus [12, 13].
Tumour necrosis factor (TNF) has been shown to be
critical in the pathogenesis of M. tuberculosis in the
central nervous system [14–16]. TNF is synthesised by
several cell types of haematopoietic origin, such as
microglia/macrophages, neutrophils, dendritic cells and
lymphocytes, and non-haematopoietic origin such as
astrocytes and neurons [17–20]. The production of
TNF in the CNS alters the BBB permeability and CSF
leukocytosis in experimental bacterial meningitis [21, 22]
and has been implicated in fostering the progression of
CNS-TB in a rabbit model [16]. However, Tobin et al.
[15] have shown using human and zebrafish models that
either state, TNF deficiency or excessive TNF production,
causes macrophage lysis, therefore placing M. tuberculosis
in a permissive extracellular niche [15, 23, 24]. Within this
context, it is important to understand the role of TNF in
host immunity during M. tuberculosis infection in the
CNS. Here, we generated neuron-specific TNF-deficient
(NsTNF−/−) mice and investigated outcomes after intrace-
rebral M. tuberculosis infection in comparative studies
with TNFf/f control and global TNF−/− mice.
Methods
Mice
All mouse strains, TNFf/f (TNF-floxed wild-type [25]),
Syn1-Cre (synapsin I promoter-driven Cre-transgenic,
obtained from the Jackson Laboratory, http://jaxmice.jax.
org/strain/003966.html), NsTNF−/− (neuron-derived TNF-
deficient) and TNF−/− (TNF-deficient [25]) mice, were
bred and maintained under specific pathogen-free condi-
tions at the animal facility of the University of Cape Town
(South Africa). Adult mice between 8 and 12 weeks of age
were used, and infected mice were maintained under bio-
safety level 3 conditions. All animal procedures were ap-
proved by the Animal Research Ethics Committee (AEC
reference number: 010/018), University of Cape Town, in
accordance with the South African National Standard.
Genotyping PCR analysis
Genotyping of mouse strains was performed by PCR
analysis of DNA extracted from tail biopsies. Genetic
analysis of TNFf/f mice was previously described [25].
Syn1-Cre and NsTNF−/− mouse were genotyped for Creexpression using the primer sets IMR1084 (5′ GCG
GTC TGG CAG TAA AAA CTA TC 3′) and IMR1085
(5′ GTG AAA CAG CAT TGC TGT CAC TT 3′), and
the internal controls IMR7338 (5′ CTA GGC CAC
AGA ATT GAA AGA TCT 3′) and IMR7339 (5′ GTA
GGT GGA AAT TCT AGC ATC ATC C 3′). For the
presence of the TNF loxP gene in NsTNF−/− mice,
primers KO41 (5′ TGA GTC TGT CTTAAC TAA CC 3′)
and KO42 (5′ CCC TTC ATT CTC AAG GCA CA 3′)
were used [25].
Aerosol infection and immunohistochemistry of
brain tissue
M. tuberculosis with green fluorescent expressing pro-
tein (M. tuberculosis H37Rv-GFP, provided by Joel Ernst,
New York University School of Medicine, USA) was
grown in Middlebrook 7H9 medium (Difco™ Laboratories)
containing 25 μg/ml kanamycin and 0.5 % glycerol and
enriched with 10 % OADC. Bacterial cultures were incu-
bated at 37 °C and grown until log phase, aliquoted and
stored at −80 °C. A frozen aliquot of M. tuberculosis was
thawed, passed 30 times through a 29-G needle and di-
luted in sterile saline. Mice were infected by aerosol inhal-
ation at a dose of 200–500 colony-forming units (CFUs)/
lung under biosafety level 3 conditions using a Glas-Col
Inhalation Exposure System Model A4224. For analysis,
infected mice were deeply anaesthetised and transcardially
perfused with 4 % paraformaldehyde. Brains were sec-
tioned at 40 μm using a vibratome and processed for
immunohistochemical staining. Neurons were labelled
with polyclonal anti-MAP2 (1 μg/ml, Abcam) or anti-β-
III-tubulin antibody (1 μg/ml, Abcam), and anti-rabbit
Cy3-conjugated secondary antibody (1.5 μg/ml, Jackson
ImmunoResearch Laboratories). The microglia/monocytes
were labelled with monoclonal anti-CD11b antibody (Clone
M1/70, 1 μg/ml, Abcam) and anti-rat Cy3-conjugated sec-
ondary antibodies (1.5 μg/ml, Jackson ImmunoResearch
Laboratories). The sections were incubated with nuclear
marker DAPI (Sigma) and then mounted in fluorescent
mounting medium and images captured using a Zeiss
510LSM unit.
Intracerebral infection and clinical scoring
M. tuberculosis strain H37Rv was grown at 37 °C in
Middlebrook 7H9 broth containing 10 % OADC and
0.5 % Tween 80 until log phase, then aliquoted and
stored at −80 °C. A frozen aliquot was thawed, passed 30
times through a 29-G needle and diluted in sterile saline.
Intracerebral infection was performed using a stereotaxic
approach of directly injecting M. tuberculosis H37Rv
into the cerebral cortex. Prior to inoculation, a small
burr hole was constructed anterior to the bregma and to
the left of the midline in the skull exposing the dura
mater. Five mice per strain were inoculated intracerebrally
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using a Hamilton syringe (Gastight no. 1701, Switzerland).
The burr hole was sealed with bone wax and the skin su-
tured. Animals received a prophylactic pain killer for
3 days at 24-h intervals. The clinical scoring system was
adapted from previous reports [26, 27]. Here, mice were
weighed and scored daily for neurologic manifestations
during the course of infection as follows: normal (no
detectable signs) = 0; head tilt = 1; motility or decrease
activity = 2; behaviour depression = 3; and moribund
state = 4. Organs of infected mice were harvested and
processed at 1, 2, 3 and 15 weeks post-infection. Haema-
toxylin and eosin (H&E)-stained brain sections at 3 weeks
post-infection were reviewed and analysed by a patholo-
gist who was blinded to the study.
Colony enumeration assay
Bacterial burdens in the brains, lungs and spleens of in-
fected mice were determined at specific time points after
infection with M. tuberculosis. Organs were weighed and
homogenised in 0.04 % Tween 80 saline. Tenfold serial
dilutions of organ homogenates were plated in duplicates
on Middlebrook 7H10 (Becton, Dickinson and Company)
agar plates containing 10 % OADC (Life Technologies,
Gaithersburg, MD) and were incubated at 37 °C for 19–21
days. The concentration of M. tuberculosis was then deter-
mined by counting the CFUs.
Flow cytometry
To determine the expression level of TNF by neurons,
TNFf/f, NsTNF−/− and TNF−/− mice were intracerebrally
stimulated with 5 μg/ml of lipopolysaccharide (LPS) for
90 min. Mice were transcardially perfused with 4 %
paraformaldehyde. For single-cell suspensions, brains
were isolated and tissue passed through a 70-μm nylon
cell strainer (Beckton and Dickinson) and washed 2×
with phosphate-buffered saline (PBS) and the cell con-
centration was determined by counting in the presence
of trypan blue. TNF expression in neurons was mea-
sured by intracellular staining through the addition of
saponin buffer to permeabilise the cells, which were
then labelled with polyclonal anti-β-III-tubulin antibody
(20 μg/ml, Abcam) and an anti-rabbit PE-conjugated
secondary antibody (1.5 μg/ml, Jackson ImmunoResearch
Laboratories), and anti-TNF antibody (TNF:Alexa 647,
Clone MP6-XT22, BD Pharmingen™).
To analyse surface marker expression in microglia,
macrophages and dendritic cells, the following anti-
bodies were used: CD11b:PerCP-Cy5-5 (Clone M1/70,
BD Pharmingen™ [2 μg/ml]); CD11c:Alexa 700 (Clone
HL3, BD Pharmingen™ [2.5 μg/ml]); CD45:APC (Clone
30-F11, BD Pharmingen™ [2 μg/ml]); CD80:FITC (16-10A1,
BD Pharmingen™ [4 μg/ml]); CD86:V450 (Clone GL1,
BD Horizon™ [4 μg/ml]) and MHCII/(I-A/I-E):PE (M5/114.15.2, BD Pharmingen™ [2 μg/ml]). Cells were washed
with PBS/0.1 % bovine serum albumin (BSA)/0.01 %
NaN3 and incubated with the appropriate antibodies for
20 min in the dark. Excess antibodies were removed by
washing cells 2× with PBS/0.1 % BSA/0.01 % NaN3.
Pelleted cells were fixed for 18–24 h in 2 % phosphate
buffered formaldehyde and analysed on a FACSCalibur
(Beckton Dickinson) flow cytometer using CellQuest
software. Microglia were defined as CD11b+CD45low,
macrophages as CD11b+CD45high and dendritic cells as
CD11c+CD45high as previously described [28, 29].
Quantification of chemokines and cytokines
Supernatants from brain homogenates were prepared for
cytokine and chemokine measurement by enzyme-linked
immunosorbent assay (ELISA) after 3 weeks subsequent
to intracerebral M. tuberculosis infection. The chemo-
kines MCP-1, MIP-1α and RANTES, and the cytokines
IL-1β, IL-12p70 and TNF (R&D Systems, Germany)
were measured using commercially available ELISA re-
agents according to the manufacturer’s instructions.
Chemokine and cytokine concentrations were measured
by absorbance using a Versamax Microplate Reader
(Molecular Devices, LLC, CA) with SoftMax software.
Statistical analysis
The data are presented as the mean ± standard error of
the mean (SD). Statistical analysis was performed by
one-way ANOVA and one-tailed t test for comparisons
amongst the time points. For all tests, a p value of ≤0.05
was considered significant.
Results
TNF regulates M. tuberculosis dissemination into the brain
but infection of neurons is TNF independent
TNF plays an important role in host immunity against
M. tuberculosis dissemination and latent infection [30–32].
A key function of TNF in granuloma formation and main-
tenance has been described in models of TNF-gene defi-
ciency or neutralisation [16, 33, 34], supported by clinical
evidence observed in the rheumatoid arthritis patients
who presented with TB reactivation after anti-TNF therapy
[5]. Moreover, inhibition of TNF leads to M. tuberculosis
dissemination which causes extrapulmonary TB including
severe CNS-TB [35, 36]. To investigate whether TNF pro-
tects against M. tuberculosis dissemination to the CNS, we
challenged wild-type (TNFf/f ) and TNF−/− mice by aerosol
inhalation with M. tuberculosis H37Rv-GFP. In contrast to
TNFf/f mice, TNF−/− mice were unable to control pulmon-
ary TB infection, which resulted in high bacilli burdens in
the lungs and spleens (Fig. 1a), similar to previous reports
[37, 38]. Further, we confirmed dissemination of M. tuber-
culosis bacilli from the lungs to the brains in the absence
of TNF; however, bacilli in the brains of TNFf/f mice were
Fig. 1 Dissemination of M. tuberculosis to the brain in TNF−/− mice. a TNFf/f and TNF−/− mice were infected by aerosol inhalation at a dose of
200–500 CFUs/lung of M. tuberculosis, and mycobacterial burden in brains, lungs and spleens was determined at day 33 post-infection. b Foci
of disseminated fluorescent bacilli (green) surrounded by CD11b+ microglia/macrophages (red) were present in the TNF−/− brain parenchyma.
c, d The fluorescent image of intracellular M. tuberculosis GFP-expressing bacilli (green) found in the neurons (red) of TNF−/− mouse, labelled
with c MAP2 and d β-III-tubulin. The orthogonal projection of confocal Z-stacks confirmed the cytosolic location of the bacilli in the x–y plane.
All nuclei were labelled with DAPI (blue in b–d). Scale bars: b 20 μm; c, d 5 μm. The data represents two independent experiments
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is supported by previous studies of Hernandez Pando et al.
[39], who showed limited, if any, detectable bacilli in the
brains of wild-type mice using the same M. tuberculosis
H37Rv laboratory strain.
Pathogenesis of CNS-TB is thought to involve haema-
togenous spread and phagocytosis of bacilli by microglia
which generates a robust immune response [1, 40]. TNF, as
a pro-inflammatory cytokine mainly produced by microglia
and astrocytes, has been proposed as the main cause of
inflammation and neuropathology [2, 40], while others have
suggested a neuroprotective role [41]. We have previously
demonstrated that neurons can serve as host cells for
M. tuberculosis [42]. Therefore, to determine if neuron
infection is TNF dependent, we investigated whether dis-
semination of M. tuberculosis to the CNS of TNF−/− mice
resulted in bacilli infection of neurons. Infected brain tissue
sections presented predominantly with bacilli foci enriched
with CD11b+ microglia/macrophages (Fig. 1b), most of
which were intracellular. Significantly, we observed M.
tuberculosis association with neurons. Three-dimensional
orthogonal views of confocal images revealed that thegreen-expressing bacilli were embedded in the MAP2+
(Fig. 1c) or β-tubulin+ (Fig. 1d) neuronal cytoplasmic
structures, similar to previously described observations in
intracranially infected C57Bl/6 mice [42]. The data pre-
sented here together with previously published data [37]
demonstrates an important role for TNF to regulate pul-
monary immune responses against M. tuberculosis infec-
tion. Failure to control M. tuberculosis replication results
in bacilli dissemination and subsequent infection of per-
ipheral organs including the central nervous system where
infection of neurons can occur independent of TNF.
Generation and characterisation of NsTNF−/− mice
Although our observations suggested TNF-independent
neuronal invasion in the CNS, it was reported that TNF
production, specifically by neurons, has an impact on
disease outcome [43]. To investigate the role of neuron-
derived TNF in CNS-TB immunity, we generated a mouse
model of neuron-specific TNF deficiency (NsTNF−/−)
through mating of Syn1-Cre mice [44] and TNF-floxed
mice (TNFf/f ) [25, 37]. We confirmed correct genotypes of
the heterozygous Syn1-CreCre/wtTNFf/wt F1 offspring by
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played the 100-bp amplification product representative of
the Cre gene (bottom panel, Fig. 2a) while both the TNF-
floxed and normal TNF genes were present, represented
by 400- and 350-bp amplification products, respectively
(top panel, Fig. 2a). Syn1-CreCre/wtTNFf/wt F1 offspring
was subsequently bred with TNFf/f mice to generate the
homozygote neuronal cell type-specific TNF mice (Syn1-
CreCre/wt TNFf/f ), and offspring were analysed by tail
biopsy analysis. The F2-generation Syn1-CreCre/wt TNFf/f
mice displayed the 400-bp amplification fragment repre-
sentative of the TNF-floxed gene while the normal wild-
type TNF gene was absent (top panel, Fig. 2a), and the
presence of a 100-bp amplification product specified the
presence of the Cre gene. The data therefore confirmed
the genotype of the new strain which was termed
NsTNF−/− mice (bottom panel, Fig. 2a).
We next assessed neuron-specific ablation of TNF.
TNFf/f, TNF−/− and NsTNF−/− mice were inoculated with
3 μl LPS (5 μg/ml) in the left brain hemisphere by intra-
cerebral inoculation. Single-cell suspensions, generated
from harvested brains, were labelled and analysed for
neurons expressing TNF. We confirmed expression of
TNF in neurons of TNFf/f mice and the absence of TNF
in both TNF−/− and NsTNF−/− mice through compara-
tive TNF mean fluorescence intensity analysis which
were both negligible in TNF−/− and NsTNF−/− mice
(Fig. 2b), indicating almost complete neuron-specific
ablation while the MFI for TNF was approximately 100-
fold higher in TNFf/f mice (Fig. 2c). Thus, the successful
generation of novel NsTNF−/− mice which presented
with neuron-specific TNF ablation was confirmed by
genetic and flow cytometric analysis.
TNF−/− mice are highly susceptible to cerebral M. tuberculosis
infection while NsTNF−/− mice are resistant
Contention exists on the role of TNF in host protection
against M. tuberculosis infection of the brain. CurrentFig. 2 Analysis of NsTNF−/− mice. a Deletion of the neuron-specific TNF ge
in neurons from TNFf/f, NsTNF−/− and TNF−/− mice was analysed by flow cy
expression in TNFf/f (green), NsTNF−/− (blue) and TNF−/− mice (red) are preseliterature argues that M. tuberculosis persistence is en-
couraged in the presence of TNF [45] whereas, in pul-
monary infection, it is required to control bacterial
replication [34, 38, 46]. Also, TNF was shown to be crit-
ical for protection against other central nervous system
diseases [17, 47]. To resolve the apparent inconsistency
in the role of TNF, particularly to address whether TNF
contributes to immune protection against M. tuberculosis
of the central nervous system, and to evaluate neurons as
a potential cellular source of TNF in the cerebral immune
response, TNFf/f, NsTNF−/− and TNF−/− mice were chal-
lenged with M. tuberculosis. Disease progression was clin-
ically scored, and mortality and changes in body weight
were recorded as indications of disease severity (Fig. 3). In
contrast to TNFf/f mice which survived infection for
15 weeks, TNF−/− mice were highly susceptible and rap-
idly succumbed to infection within 3 weeks (Fig. 3b).
Initial post-surgery body weight loss and recovery were
observed between day 1 and day 5 after M. tuberculosis in-
fection as previously reported [48, 49]. Susceptibility was
accompanied by rapid loss of >20 % of the original body
weight during the last week of illness as opposed to TNFf/f
mice which displayed a steady increase in body weight
during the same observation period (Fig. 3a). Similar to
TNFf/f mice, NsTNF−/− mice were resistant and survived
the duration of infection without any measured body
weight loss. Brain, lung and spleen weights were measured
as representative of organ inflammation during disease de-
velopment. We observed enhanced brain inflammation in
all three strains until 2 weeks post-infection, after which
inflammation was sustained in TNFf/f and NsTNF−/− mice
but significantly decreased (p < 0.05) in TNF−/− mice
(Fig. 3a). Neurologic symptoms such as head tilt and an-
orexia were absent in both TNFf/f and NsTNF−/− mouse
strains, contrasting the severe clinical neurologic symp-
toms prominent (p < 0.01) within 16–21 days post-
infection in TNF−/− mice (Fig. 3d). It was therefore con-
cluded that TNF was indispensable to generate protectivene in NsTNF−/− mice was confirmed by PCR analysis. b TNF expression
tometry after LPS stimulation. c Mean fluorescence intensities of TNF
nted
Fig. 3 TNF−/− mice are highly susceptible to CNS-TB but NsTNF−/− mice are resistant. TNFf/f (black circle), NsTNF−/− (triangle), and TNF−/− (clear circle)
mice were infected with M. tuberculosis H37Rv at a dose of 1 × 103–1 × 104 CFUs/brain by intracerebral inoculation. Body weight changes (a) and
mortality (b) were measured and recorded for the experimental duration (n = 10–12 mice/group). c Brain weights of infected mice were recorded at 1,
2 and 3 weeks post-infection (n = 5–6 mice/group). d The clinical scores, indicative of the disease severity, are represented (n = 10–12 mice/group).
The data represents three to five similar experiments. *p ≤ 0.05
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nervous system and unequivocally established the non-
redundancy of TNF as a critical mediator of immune
protection against CNS-TB. Nonetheless, while TNF was
required for protection, neuron-specific TNF was func-
tionally redundant.
Cerebral bacilli replication and dissemination are
increased in TNF−/− mice but not in NsTNF−/− mice
The importance of TNF to control cerebral bacilli repli-
cation was assessed by comparing pathogen burden in
the brains of M. tuberculosis-infected TNFf/f, NsTNF−/−
and TNF−/− mice. We observed an increase in cerebral
M. tuberculosis replication in TNFf/f mice during acute
infection, burdens at week 3 post-infection being sig-
nificantly higher compared to those at earlier time
points (Fig. 4a). In contrast, differences in cerebral bacilli
burden were already significantly higher (p < 0.01) in
TNF−/− mice at 2 weeks post-infection which were sus-
tained at 3 weeks post-infection. In contrast, NsTNF−/−
mice controlled acute infection at burden levels equivalent
to those in TNFf/f mice and were similarly significantly
lower (p < 0.01) compared to those in TNF−/− mice
(Fig. 4a). We confirmed differences in cerebral bacilli bur-
den by image analysis of acid-fast bacilli staining (Fig. 5).
In the brains of TNFf/f and NsTNF−/− mice, acid-fast ba-
cilli were located either in the choroid plexus, in theventricular space or in the perivascular region at 3 weeks
post-infection. However, in TNF−/− mice, necrotic foci
containing significantly higher numbers of bacilli were
prominent in the brain parenchyma (Fig. 5). We then
asked whether neuron-derived TNF is required to control
chronic cerebral M. tuberculosis infection. We found no
difference in cerebral bacilli burdens between TNFf/f and
NsTNF−/− mice (Fig. 4b), indicating that TNF synthesis by
neurons is not required to control infection. We next
measured bacilli burdens in the lungs and spleens of in-
fected mice to evaluate the role of TNF to control M. tu-
berculosis dissemination from the brain. Pulmonary and
splenic infection was established early in the absence of
TNF and bacilli burdens significantly higher than TNFf/f
or NsTNF−/− mice (Fig. 4c, e), indicating that TNF is re-
quired to control early dissemination of infection. The
comparative equivalence of bacilli burdens in both the
lungs and spleens of TNFf/f and NsTNF−/− mice during
acute (Fig. 4c, e) or chronic infection (Fig. 4d, f ) suggested
a redundancy of neuron-derived TNF to contain cerebral
spread of infection.
TNF regulates cerebral inflammation but neuron-derived
TNF is not required
We next examined the role of TNF to control cerebral
inflammation by analysis of sectioned brain tissue for
induced pathology in M. tuberculosis-infected mice at
Fig. 4 (See legend on next page.)
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Fig. 4 TNF is required to control intracerebral M. tuberculosis replication but neuron-derived TNF is redundant. TNFf/f (black circle), NsTNF−/− (triangle)
and TNF−/− (clear circle) mice (n = 5–6/group) were infected with M. tuberculosis at a dose of 1 × 103–1 × 104 CFUs/brain. Bacterial burdens in
a, b brains; c, d spleens; and e, f lungs at 1, 2, 3 (left panel; a, c, e, respectively) and 15 weeks (right panel; b, d, e respectively) post-infection were
determined. Data (mean ± SEM of the CFUs of 5–6 mice per time point) are representative of three similar experiments. *p ≤ 0.05; **p ≤ 0.01
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TNFf/f, NsTNF−/− and TNF−/− mice, we observed de-
grees of inflammation in different regions of the brain in
all mouse strains (Fig. 5). Representative images of in-
flammation in the choroid plexus, ventricles and brain
tissue are shown in Fig. 5b, e, h, respectively. Amongst
the three mouse strains, TNF−/− mice exhibited the most
severe neuropathology and uncontrolled inflammation
where acute ventriculitis was characterised by a pro-
minent neutrophil infiltrate which extended into the
periventricular tissue (Fig. 5g). The choroid plexus in
TNF−/− mice was infiltrated by a mixture of lymphocytes
and neutrophils in contrast to a predominantly lympho-
cytic infiltrate in TNFf/f and NsTNF−/− mice. Also noted
were associated foci of necrosis in the adjacent brain
tissue with distinct areas of perivascular lymphocyte
cuffing (Fig. 5h). Well-formed, discrete granulomas were
present in TNFf/f and NsTNF−/− mice unlike in TNF−/−
mice where granuloma formation was largely absent.
Therefore, TNF was required to regulate CNS inflam-
mation during M. tuberculosis infection; moreover, it de-
termined the quality of the inflammatory response.Fig. 5 Cerebral pathology is regulated by TNF but neuron-derived TNF is not
with M. tuberculosis H37Rv at a dose of 1 × 103–1 × 104 CFUs/brain by intrace
sections at 3 weeks post-infection are presented (a, d, g). Ventriculitis of the c
while a predominant neutrophil infiltrate accompanied by necrosis is observe
mainly in the choroid plexus (c, arrow) and ventricular space (f, arrow) in TNFf
in brain parenchyma (i) in TNF−/− mice. The granuloma was found in TNF−/−TNF regulates recruitment and proliferation of innate
immune cells
Early susceptibility of TNF−/− mice to cerebral M. tubercu-
losis infection suggested defective TNF-mediated function
during initial innate immune responses. We postulated
that TNF deficiency may impact on key innate immune
cell function to promote the observed susceptible pheno-
type. We first investigated recruitment of macrophages
and dendritic cells to the brain and evaluated proliferation
of microglia, as central mediators of innate immune
responses subsequent to M. tuberculosis challenge. Micro-
glial proliferation and dendritic cell and macrophage re-
cruitment occurred in all three mouse strains in response
to M. tuberculosis infection (Fig. 6a–c). However, while
cellular levels reached maximum at 2 weeks post-infection
and were sustained at 3 weeks post-infection in TNFf/f
and NsTNF−/− mice, TNF−/− mice displayed significantly
higher levels at 2 weeks post-infection, the differential
levels enhancing even further at 3 weeks post-infection.
We next investigated whether enhanced innate immune
cell recruitment in TNF−/− mice was a consequence of
heightened host cerebral chemokine induction in responserequired. a–c TNFf/f, d–f NsTNF−/− and g–i TNF−/− mice were infected
rebral inoculation. Haematoxylin and eosin-stained coronal brain tissue
horoid plexus is primarily lymphocytic in b TNFf/f and e NsTNF−/− mice
d in h TNF−/− mice. Ziehl–Neelsen staining revealed acid-fast bacilli
/f and e NsTNF−/− mice while infiltration of bacilli was frequently observed
mouse brain (circle in h, i). Scale bars 20 μm
Fig. 6 TNF regulates innate immune cell proliferation and recruitment during CNS-TB. TNFf/f (black), NsTNF−/− (grey) and TNF−/− (clear) mice were
infected with M. tuberculosis H37Rv at a dose of 1 × 103–1 × 104 CFUs/brain by intracerebral inoculation. The number of a microglia, b macrophages
and c dendritic cells was analysed by flow cytometry at 0, 1, 2 and 3 weeks in infected brains. The chemokines d MIP-1α, e MCP-1 and f RANTES were
measured by ELISA in the brains of infected mice at 3 weeks post-intracerebral infection. Data (mean ± SEM of the CFUs of 5–6 mice per time point)
are representative of repeat experiments. *p ≤ 0.05; **p ≤ 0.01
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centrations of MIP-1α, MCP-1 and RANTES in M. tuber-
culosis-infected mice representative of chemokines known
to induce pro-inflammatory effects [50, 51]. We found
escalating induction of each chemokine in the brains of
infected mice over the duration of the experiment (data
not shown). However, while TNFf/f and NsTNF−/− mice
produced equivalent chemokine concentrations, TNF−/−
mice synthesised significantly higher levels (p < 0.01) of
MIP-1α, MCP-1 and RANTES at 3 weeks post-infection
(Fig. 6d–f). The positive correlation between higher
chemokine concentrations and enhanced cellular inflam-
mation in TNF−/− mice suggests an unregulated TNF-
dependent chemokine response driving uncontrolled cell
recruitment in response to M. tuberculosis infection.
Thus, while immune cell recruitment and proliferation
were TNF dependent, neuron-derived TNF was redundant
for this function.
TNF deficiency renders cerebral innate immune cells
functionally defective
The increased presence of innate immune cells in the
absence of TNF supports the potential for improved
early control of cerebral M. tuberculosis, yet TNF−/−
mice display a highly susceptible phenotype. We postu-
lated that early susceptibility may be associated with
defective function of innate immune cells during initial
infection. We therefore investigated the capacity ofmicroglia, macrophages and dendritic cells to present
antigen by analysing expression of MHCII, CD80 and
CD86 (Fig. 7). We observed comparable expression of
CD80, CD86 and MHCII in TNFf/f and NsTNF−/− mice
at each of the time points investigated, indicating that
neuron-derived TNF does not regulate innate immune
cell activation. In contrast, although TNF−/− mice pre-
sented with equivalent levels of immune-activated cells
during the first 2 weeks of infection compared to TNFf/f
and NsTNF−/− mice, they fail to sustain the required
level of activation and significantly lower (p < 0.05)
levels of activated innate immune cells were measured
at 3 weeks post-infection.
To further investigate innate immune cell functional-
ity, we measured levels of TNF, IL-1β and IL-12p70 in
the brain homogenates of TNFf/f, NsTNF−/− and TNF−/−
mice after 3 weeks of intracranial infection (Fig. 8). The
induction of TNF in TNFf/f mice confirmed its require-
ment as part of initial protective immune responses,
while equivalent expression in NsTNF−/− mice indicated
neurons redundant as a TNF source (Fig. 8a). As expected,
no TNF production was detected in TNF−/− mice (Fig. 8a).
Similar levels of IL-1β (Fig. 8b) and IL-12p70 (Fig. 8c) pro-
duction were observed in TNFf/f and NsTNF−/− infected
brains. In contrast, the concentration of cerebral IL-1β
and IL-12p70 in infected TNF−/− mice was significantly
(p < 0.05) lower than in TNFf/f and NsTNF−/− mice.
Therefore, the data indicates that TNF is required to
Fig. 7 Expression of CD80, CD86 and MHCII in microglia, macrophages and dendritic cells is TNF dependent. TNFf/f (black circle), NsTNF−/− (triangle)
and TNF−/− (clear circle) mice were infected with M. tuberculosis H37Rv at a dose of 1 × 103–1 × 104 CFUs/brain by intracerebral inoculation. Single-cell
suspensions of brains at 0, 1, 2 and 3 weeks post-infection were generated and microglia (a–c), macrophages (d–f) and dendritic cells (g–i) analysed
for expression of CD80 (a, d, f), CD86 (b, e, h) and MHC II (c, f, i). Data (mean ± SEM of the CFUs of 5–6 mice per time point) are representative of
repeat experiments. **p ≤ 0.01
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Fig. 8 TNF regulates synthesis of IL-1β and IL-12p70. TNFf/f (black), NsTNF−/− (grey) and TNF−/− (clear) mice were infected with M. tuberculosis H37Rv
infection at a dose of 1 × 103–1 × 104 CFUs/brain by intracerebral inoculation. a TNF, b IL-1β and c IL-12p70 cerebral concentrations were measured
by ELISA at 3 weeks post-infection. Data (mean ± SEM of the CFUs of 5–6 mice per time point) are representative of repeat experiments. *p ≤ 0.05
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that neuron-derived TNF is not important.
Discussion
TNF concentration forms a pivotal point of balance that
determines outcome of disease during M. tuberculosis
infection. Susceptibility is promoted either under condi-
tions where excess TNF prevails or low TNF concentra-
tions are present [15, 16, 23, 24]. Under such polar
conditions, either macrophage/cell effector function is
impaired which leads to intracellular mycobacterial rep-
lication and eventual cell lysis or excessive TNF levels
promote macrophage necrosis, in so doing enrich condi-
tions for bacilli growth. Diverse cell types can act as con-
tributory sources of TNF (during pathogenic challenge)
and may therefore be differential contributors to the
TNF environment required for optimum mycobacterial
control. It is known that microglia, as resident immune
cells of the CNS, express TNF and that recruited den-
dritic cells and macrophages will similarly induce TNF
during pathogen challenge [40, 52, 53]. Neurons, as the
single most abundant cell type within the CNS, are cap-
able of regulating immune responses during CNS insult
[54, 55]. We have reported M. tuberculosis targeting of
neurons and its capability to generate reactive immune
responses [42]; however, its role in M. tuberculosis con-
trol remains largely untested. In the presence of patho-
gens, neurons induce specific cytokine signatures, TNF
comprising a key component of many such signature re-
sponses. The synthesis of TNF by neurons was observed
after systemic immune challenge [56]. Upon viral infec-
tion, both in vitro and clinical studies have shown TNF
expression in neurons [57–60]. In other neurological dis-
eases, upregulation of neuronal TNF expression has pro-
vided an indication to the severity of disease progression
and inflammatory neuropathology [43, 61–63]. In view of
these findings, we postulated that neuron-derived TNFmay have a contributory role to regulate CNS immunity
during M. tuberculosis infection. We therefore investi-
gated the overall contribution of TNF and in particular
the involvement of neuron-derived TNF in host-mediated
immunity directed against M. tuberculosis during central
nervous system infection. Several converging lines of
study/evidence have indicated a neuroprotective role for
TNF and its induction demonstrated to be a key deter-
minant of disease outcome during cerebral infection [64].
In this study, we initially demonstrated that global TNF is
critical to control M. tuberculosis dissemination to the
CNS and regulates immune-mediated brain pathology
during infection. Moreover, we demonstrate for the first
time that TNF is an absolute requirement to mediate pro-
tective immunity against CNS-TB; however, neuron-
derived TNF is considered redundant. Thus, host suscep-
tibility to CNS-TB in the absence of TNF corroborates its
significance in neuroprotective immunity. Although the
findings in this study appear contrasting to those of Tse-
nova et al., where TNF was reported to promote mycobac-
terial onset of disease and pathogenesis [16], it is not
unexpected and may rather reflect opposite ends of the
TNF functionality spectrum as previously reported [23,
24]. TNF concentration in dynamic homeostasis is abso-
lutely essential for effective control of M. tuberculosis in-
fection, a shift in balance that favours either excessive or
reduced levels being detrimental to the host that promotes
conditions for mycobacterial persistence.
Mycobacterial infection of the CNS generates a robust
immune response characterised by both pro-inflammatory
and anti-inflammatory immune cellular and cytokine pro-
files [65]. While microglia were reported to be the primary
source of TNF during CNS infection [65], we and others
have shown that different cell types have hierarchical im-
portance as sources of TNF in determining the outcome
of tuberculosis disease [37]. TNF derived from T cells
critically defines resolution of pulmonary infection, while
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tuberculosis replication [37]. Our findings however ascribe
neurons as a redundant cellular source of TNF to control
M. tuberculosis infection or regulate immune pathology
and suggest a far greater role for other resident or re-
cruited cells to produce TNF. Interestingly, others have
reported that TNF produced by neurons is redundant
for mediating inflammation but that membrane TNF
expressed on astrocytes has a functional role [66].
Nonetheless, the overall requirement of TNF for control
of both mycobacterial replication and immune-mediated
pathology was evident and the rapid rate of host suscepti-
bility suggested immune deficiency during early infection.
Brain pathology, particularly at end-stage disease, was
characterised by increased inflammation of dendritic cells
and macrophages, and microglial proliferation which was
underpinned by an enhanced pro-inflammatory chemo-
kine environment in the absence of TNF. These observa-
tions align with earlier reports of a regulatory role for
TNF in inflammation during M. tuberculosis infection
[67]. In earlier studies, we reported on a deregulated over-
all cytokine and chemokine response in the absence of
TNF during pulmonary tuberculosis [37]. We show here a
neutrophil-dominant pathology in TNF−/− mice also asso-
ciates with a similar unregulated increase in chemokine
synthesis during CNS-TB. Moreover, a lethal neutrophil-
driven inflammatory response associated with, amongst
others, MIP-1α in the absence of microRNA 223 in pul-
monary tuberculosis was reported [68]. Taken together,
the data suggest that perturbation of controlled host im-
mune regulation which promotes a dominant neutrophilic
response leads to increase susceptibility with fatal conse-
quences. Selective inhibition of neutrophil recruitment
under conditions of immune suppression during tubercu-
losis should therefore be considered.
Microglia, macrophages and dendritic cells as the main
facilitators of early innate immune protection are activated
in a TNF-dependent manner [69, 70]. We therefore postu-
lated that early host susceptibility of TNF−/− mice was the
result of defective activation of innate antigen-presenting
immune cells during early infection. Activation of macro-
phages, dendritic cells and microglia within the first
2 weeks of infection appeared to be independent of TNF
with equivalent levels of activated cells evident in TNFf/f,
NsTNF−/− and TNF−/− mice; however, the ability to subse-
quently sustain the required measures of activated cells
was TNF dependent. These cells which are critical effec-
tors of early innate immunity were rendered functionally
defective in the absence of TNF. Initial cytokine signature
responses by innate immune cells include synthesis of
IL-12 and IL-1 [71, 72], both of which are critical to con-
trol tuberculosis infection [14, 73–75]. Mice deficient for
either cytokine develop rapid onset of disease and suc-
cumb to infection, while patients with defective IL-12signalling display susceptibility to tuberculosis infection.
Maturation of antigen-presenting cells is characterised by
the expression of, amongst others, MHCII and CD80 [76]
during M. tuberculosis infection and is mediated largely by
the presence of IL-1 and TNF [77, 78]. Moreover, IL-12
synthesis by mature activated dendritic cells is dependent
on TNF-mediated signalling [78] and is a key cytokine re-
quired to restrict bacilli replication. Here, we observed
that maturation of microglia, dendritic cells and macro-
phages initially occurs independent of TNF; however, sus-
tained cell activation was TNF dependent. The deficiency
in IL-12 and IL-1β synthesis in the CNS when TNF is ab-
sent argues strongly for functional failure of innate im-
mune cells and inability to effectively participate in control
of M. tuberculosis. Moreover, the reduction of MHCII- and
CD80-expressing cells indicated reduced capacity to initi-
ate M. tuberculosis-specific Th1 protective immune re-
sponses required for control of intracellular bacilli, and
hence predisposed the host to a susceptible phenotype.
Conclusion
In conclusion, the findings in this study corroborate
earlier reports of the global importance of TNF in
immune-mediated responses against tuberculosis and
for the first time demonstrate its importance to control
M. tuberculosis replication within the CNS. We further
showed that neuron-derived TNF is not required for
this process.
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